CNS & Neurological Disorders-Drug Targets

Papers
(The H4-Index of CNS & Neurological Disorders-Drug Targets is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model54
Scopolamine, a Toxin-Induced Experimental Model, Used for Research in Alzheimer’s Disease47
The Role of Annexin A1 and Formyl Peptide Receptor 2/3 Signaling in Chronic Corticosterone-Induced Depression-Like behaviors and Impairment in Hippocampal-Dependent Memory44
Inflammation and Mitochondrial Dysfunction in Autism Spectrum Disorder35
When Sick Brain and Hopelessness Meet: Some Aspects of Suicidality in the Neurological Patient34
Benzodiazepines and Sleep Architecture: A Systematic Review29
Role of Calcium Homeostasis in Ischemic Stroke: A Review26
Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol25
MAPK: A Key Player in the Development and Progression of Stroke24
Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment23
Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases23
Stingless Bee Honey Reduces Anxiety and Improves Memory of the Metabolic Disease-induced Rats19
Arachidonic Acid Derivatives and Neuroinflammation19
Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic17
Current Strategies and Novel Drug Approaches for Alzheimer Disease17
Detection, Treatment Planning, and Genetic Predisposition of Bruxism: A Systematic Mapping Process and Network Visualization Technique17
ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders17
0.03650689125061